Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1958 of 5804
-
Phone reminders boost childhood vaccination rates in low-resource areas
⭐️ VACCINE ⭐️ CompletedSupported be a digital vaccine registry the investigators will test the impact of automated appointment reminders, real time appointment reminders, motivational interviewing and targeted vaccine on routine childhood vaccine completion rates.
Phase: NA • Sponsor: Indiana University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:05 UTC
-
Could a blood clot drug ease arthritis pain?
Disease control CompletedThe goal of this study is to evaluate the effect of cilostazol on Rheumatoid Arthritis patients. It aims to answer the questions of : 1. Will Cilostazol improve the disease severity and quality of life in Rheumatoid arthritis patients? 2. Will Cilostazol decrease the oxidative s…
Phase: PHASE2, PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New wearable device could uncover hidden stroke cause
Diagnosis CompletedThe aim of the study is to evaluate the efficacy and safety of the Cardea SOLO Compared to 12 lead EKG for Paroxysmal Atrial Fibrillation Diagnosis in ESUS patients with Left Atrial Enlargement.
Phase: NA • Sponsor: Asan Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
Experimental CAR T-Cell therapy targets rare B-Cell cancers
Disease control TerminatedMaster protocol: The goal of this master clinical study is to test how well the study drug, brexucabtagene autoleucel, works in participants with rare B-cell malignancies: relapsed/refractory Waldenstrom macroglobulinemia (r/r WM) (Substudy A), r/r Richter transformation (RT) (Su…
Phase: PHASE2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New social therapy aims to lift postpartum depression by fighting isolation
Symptom relief Recruiting nowThis randomized controlled trial compares a novel psychotherapy, Engage \& Connect, with a Symptom Review and Psychoeducation intervention, tailored to reduce postpartum depression. The study includes 9-weeks interventions, delivered remotely. It will examine changes in social is…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New study seeks clues to why some get PAH and others Don't
Knowledge-focused Recruiting nowPulmonary arterial hypertension (PAH) is a severe disease with a delayed diagnosis and markedly elevated mortality. High-risk populations, such as those with known genetic defects, provide a unique opportunity to determine the features of susceptibility and resilience to PAH. Thi…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New drug targets rare lung cancer gene in small trial
Disease control Recruiting nowThe purpose of this study is to find out whether ZEN003694 is an effective treatment for people with advanced squamous cell lung cancer with a mutation in the NSD3 gene. ZEN003694 is a type of drug called a BET inhibitor. Researchers think ZEN003694 may help here because the dru…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Stomach 'EKG' could spot hidden gut problems
Diagnosis ENROLLING_BY_INVITATIONThis is an analytical validation observational cohort study is designed to provide evidence of: safety and reliability of Body Surface Gastric Mapping using the Gastric Alimetry System (GAS), normal reference values, and correlation of metrics with patient symptoms among healthy …
Sponsor: University of Calgary • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New shot could replace IV drips for rare muscle disease
Disease control CompletedThe purpose of the study is to evaluate the safety and tolerability of switching from intravenous (IV) complement component 5 (C5) inhibitors to subcutaneous (SC) Zilucoplan in study participants with generalized myasthenia gravis (gMG)
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 26, 2026 13:12 UTC
-
Could a simple electrical device ease chronic pelvic pain?
Symptom relief Recruiting nowMyofascial Pelvic Pain (MPP) is a frequently overlooked musculoskeletal cause of chronic pelvic pain affecting 10-20% of all adult women. Despite high prevalence and societal costs, few effective treatments exist and are difficult to access due to shortages of skilled personnel. …
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Stool DNA test may offer easier cancer monitoring
Diagnosis Recruiting nowThe purpose of this research study is to determine whether testing of stool for a panel of markers will enable us to detect polyps and cancer compared to standard testing.
Sponsor: Case Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
New pill aims to heal Acid-Damaged esophagus
Disease control CompletedThe objective of the Healing Phase of the study is to evaluate the safety and efficacy of up to 8 weeks of once daily oral administration of BLI5100 versus a PPI control in healing EE. The objective of the Maintenance Phase of the study is to evaluate the safety and efficacy of 2…
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Elbow fracture showdown: surgery vs. casting in kids
Disease control Recruiting nowThis protocol describes a multicenter, prospective randomized and patient preference cohort superiority trial of medial epicondyle fracture treatments comparing functional outcomes between children treated with operative reduction and fixation or non-operative immobilization.
Phase: NA • Sponsor: Joseph Janicki • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New study aims to make HIV prevention easier for black women
Prevention CompletedThe purpose of the study is to evaluate the appropriateness, adoption, feasibility, fidelity, and acceptability of implementation strategies and Cabotegravir (CAB) pre-exposure prophylaxis (PrEP). The study objectives are also to identify barriers and facilitators to implementati…
Phase: PHASE4 • Sponsor: ViiV Healthcare • Aim: Prevention
Last updated Jun 27, 2026 09:03 UTC
-
New flu vaccine shows promise for teens and adults
⭐️ VACCINE ⭐️ CompletedThe purpose of this study was to demonstrate the non-inferiority (NI) of the HAI immune response of RIV4 in participants aged 9 to 17 years vs participants aged 18 to 49 years and to describe the immunogenicity and safety profile of RIV4 in all participants.
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 14:35 UTC
-
New vaccine aims to shield seniors from pneumonia
⭐️ VACCINE ⭐️ Recruiting nowThe purpose of this study is to learn about how well the 20-valent pneumococcal conjugate vaccine (20vPnC) works against radiologically-confirmed community-acquired pneumonia (RAD+CAP) due to the 7 new serotypes (types of a bacteria called Streptococcus pneumoniae that cause pneu…
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:31 UTC
-
New MRI technique could spot eye strokes faster
Diagnosis Recruiting nowThe patient presents to the ophthalmological emergencies and / or to the internal medicine department. NOIA clinical discovery Patient referred in radiology for brain and visual MRI. The two sequences added by the research (8 minutes) will be added to that of the treatment.
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Lung cancer drug under the microscope: how does cemiplimab perform in real life?
Knowledge-focused Recruiting nowThis study is focused on patients with non-small cell lung cancer (NSCLC) and have been prescribed a cemiplimab (Libtayo®) based treatment regimen under standard care. The goal of this study is to learn more about the use, benefits, and safety of cemiplimab based treatment regim…
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Heart failure drug shows promise for Non-Diabetic patients
Disease control CompletedThe clinical benefits of the dual Sodium-Glucose cotransporter (SGLT) 1 and 2-inhibition have recently been reported in two clinical trials. The SOLOIST reported the benefits of sotagliflozin in Type-2 Diabetes Mellitus (T2DM) patients hospitalized for worsening of Heart Failure …
Phase: PHASE4 • Sponsor: Juan Badimon • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Gym workouts boost recovery in young adults on antipsychotics
Symptom relief CompletedThis is a multicentre, pragmatic, randomised controlled trial to estimate the effect of a 4-month gym-based exercise training program on 1) patient-rated personal recovery (primary outcome), 2) Health-related quality of life, behavioral and functional symptoms, and cardiometaboli…
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC